Ledger.Open graph →
SEC Form D · filed March 29, 2024

SELLAS Life Sciences Group, Inc

Offering
$18.4M
Sold
$18.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

David A. Scheinberg · New York, NYDirectorAngelos M. Stergiou · New York, NYExec · DirectorJohn T. Burns · New York, NYExecJohn V. Varian · New York, NYDirectorJane V. Wasman · New York, NYDirectorPatrick M. Tenney · Mill Valley, CADirectorJohn D. Botti · Mill Valley, CADirectorOlivier R. Cillien · San Juan, Puerto RicoDirectorGabriel R. Jimenez-Fernandez · San Juan, Puerto RicoExecA. M. Waldron · Mill Valley, CAExec · DirectorRobert V. Nostrand · New York, NYDirectorKatherine B. Kalin · New York, NYDirectorDavid Richmond · SAN RAMON, CAExecRinda Sama · SAN RAMON, CADirectorAndrew Hinson · SAN RAMON, CADirectorChristopher Wolff · SAN RAMON, CAExec · DirectorThaseegaran Pillay, M.D · SAN RAMON, CADirectorRobert V. Nostrand · New York, NYDirectorKatherine B. Kalin · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗